NANCY CHEEKS: Open Payments
NPI 1588146633 · HAYESVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$513 in 33 payments from 11 companies in 2025. Trend: 2023 $646 · 2024 $501 · 2025 $513
Food & beverage: $513
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $138 |
| AstraZeneca Pharmaceuticals LP | 5 | $89 |
| Amgen Inc. | 4 | $65 |
| PFIZER INC. | 3 | $46 |
| Novo Nordisk Inc | 2 | $37 |
| Lilly USA, LLC | 2 | $36 |
| Axsome Therapeutics, Inc. | 1 | $28 |
| Teva Pharmaceuticals USA, Inc. | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
Products named: VRAYLAR, FARXIGA, OTEZLA, QULIPTA, NURTEC ODT, UBRELVY, Auvelity, AUSTEDO XR.
Industry payments across NC — which companies pay providers there.
